Evidence map›Paper›PMID 14623771›Full record

ArticleBritish journal of pharmacology2003

Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.

Juan Carlos G Marvizon, Xueren Wang, Li-Jun Lao, Bingbing Song

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2005
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Juan Carlos G MarvizonDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. marvizon@ucla.edu
Xueren Wang
Li-Jun Lao
Bingbing Song
University of California, Los Angeles · US

Funding

Spinal Opioid Release in NociceptionR01DA012609 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARVIZON, JUAN CARLOS GARCIA · 2000 to 2008
$2.2M
NIDA NIH HHS R01 DA012609NIDA NIH HHS R01-DA12609
6 · The paper itself

Abstract

The ability of peptidases to restrict neurokinin 1 receptor (NK1R) activation by exogenously applied or endogenously released neurokinins was investigated by measuring NK1R internalization in rat spinal cord slices. Concentration-response curves for substance P and neurokinin A were obtained in the presence and absence of 10 microm thiorphan, an inhibitor of neutral endopeptidase (EC 3.4.24.11), plus 10 microm captopril, an inhibitor of dipeptidyl carboxypeptidase (EC 3.4.15.1). These inhibitors significantly decreased the EC50 of substance P to produce NK1R internalization from 32 to 9 nm, and the EC50 of neurokinin A from 170 to 60 nm. Substance P was significantly more potent than neurokinin A, both with and without these peptidase inhibitors. In the presence of peptidase inhibitors, neurokinin B was 10 times less potent than neurokinin A and 64 times less potent than substance P (EC50=573 nm). Several aminopeptidase inhibitors (actinonin, amastatin, bacitracin, bestatin and puromycin) failed to further increase the effect of thiorphan plus captopril on the NK1R internalization produced by 10 nm substance P. Electrical stimulation of the dorsal root produced NK1R internalization by releasing endogenous neurokinins. Thiorphan plus captopril increased NK1R internalization produced by 1 Hz stimulation, but not by 30 Hz stimulation. Therefore, NEN and DCP restrict NK1R activation by endogenous neurokinins when they are gradually released by low-frequency firing of primary afferents, but become saturated or inhibited when primary afferents fire at a high frequency.

Indexed as

Neurokinin-1 Receptor AntagonistsAminopeptidasesAnimalsElectric StimulationEnzyme InhibitorsImmunohistochemistryIn Vitro TechniquesMicroscopy, ConfocalNeurokinin ANeurokinin BRatsRats, Sprague-DawleyReceptors, Neurokinin-1Spinal CordSpinal Nerve RootsSubstance PAminopeptidasesEnzyme InhibitorsNeurokinin-1 Receptor AntagonistsNeurokinin ANeurokinin BReceptors, Neurokinin-1Substance P

Identifiers

PMID14623771
PMCPMC1574162
OpenAlexW2059744465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.